-Reuters
Related Posts
Bristol Myers’ Mavacamten Added Via $13B Myokardia Buyout, Hit By FDA Delay
Bristol Myers Squibb & Co (NYSE:BMY) has announced that the FDA has extended the decision date for mavacamten. Bristol Myers announced…
Elon Musk, Twitter May Move To End Legal Fight Soon: Reuters
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk and Twitter Inc (NYSE: TWTR) may reportedly reach a deal to end